A recent survey found that 82% of pharmaceutical industry professionals believe that digital transformation will either significantly or moderately shorten the drug development timeline.

Tesla has reiterated its plan to begin production of a more affordable electric vehicle in the first half of 2025, maintaining the timeline despite conflicting reports and ongoing industry skepticism.